Alok A. Khorana, MD (he/him/his)

Professor of Medicine
Cleveland Clinic and Case Comprehensive Cancer Center
Cleveland, Ohio, United States

Alok A. Khorana, MD, FACP, FASCO is the Sondra and Stephen Hardis Chair in Oncology Research, Professor of Medicine and Vice Chair, Taussig Cancer Institute, Cleveland Clinic and Case Comprehensive Cancer Center, Cleveland, Ohio. His NIH- and CDC-funded program is focused on prediction, prevention and treatment of thromboembolism in cancer patients and on microbiomic and metabolomic profiling of young-onset gastrointestinal cancers. He is current Chair of the Medical and Scientific Advisory Board of the National Blood Clot Alliance.He was previously Chair of the ISTH Scientific Subcommittee on Hemostasis and Malignancy.

Presentation(s):

• OC 36.6 - Venous Thromboembolism Risk Prediction in Cancer Patients

  Monday, June 26, 2023
  10:45 – 12:00 ET

• PB0934 - The Safety and Efficacy of Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in the Treatment of Thromboembolism (TE) in Patients with Hematological Malignancies

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0963 - Clinical Outcomes of Anticoagulation for The Treatment of Thromboembolism (TE) in Elderly Cancer Patients

  Monday, June 26, 2023
  18:30 – 19:30 ET

• OC 54.1 - Effectiveness and Safety of Rivaroxaban and Low Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism: A Meta-Analysis of OSCAR Programme Findings

  Tuesday, June 27, 2023
  10:45 – 11:00 ET